{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "REGULUS THER.COMPAR DL001", "longName": "Regulus Therapeutics Inc.", "messageBoardId": "finmb_36742485", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 15.55555, "regularMarketPrice": 1.56, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1377064800000, "priceHint": 4, "epsTrailingTwelveMonths": -1.66, "sharesOutstanding": 16840300, "bookValue": 1.977, "fiftyDayAverage": 1.0805, "fiftyDayAverageChange": 0.47949994, "fiftyDayAverageChangePercent": 0.44377598, "twoHundredDayAverage": 1.416455, "twoHundredDayAverageChange": 0.14354491, "twoHundredDayAverageChangePercent": 0.10134096, "marketCap": 27225588, "priceToBook": 0.7890743, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.20999992, "regularMarketTime": 1683871215, "regularMarketDayHigh": 1.56, "regularMarketDayRange": "1.56 - 1.56", "regularMarketDayLow": 1.56, "regularMarketVolume": 535, "regularMarketPreviousClose": 1.35, "bid": 1.55, "ask": 1.61, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.56, "averageDailyVolume3Month": 9, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.8349999, "fiftyTwoWeekLowChangePercent": 1.151724, "fiftyTwoWeekRange": "0.725 - 3.0", "fiftyTwoWeekHighChange": -1.44, "fiftyTwoWeekHighChangePercent": -0.48000002, "fiftyTwoWeekLow": 0.725, "fiftyTwoWeekHigh": 3.0, "earningsTimestamp": 1683801000, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "7RG0.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4224 Campus Point Court", "address2": "Suite 210", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 202 6300", "website": "https://www.regulusrx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph P. Hagan M.B.A.", "age": 53, "title": "Pres, CEO & Director", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 920728, "fmt": "920.73k", "longFmt": "920,728"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Crispina  Calsada CPA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 500866, "fmt": "500.87k", "longFmt": "500,866"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christopher Ray Aker J.D.", "age": 61, "title": "Sr. VP, Gen. Counsel & Corp. Sec.", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 524790, "fmt": "524.79k", "longFmt": "524,790"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel J. Penksa", "age": 36, "title": "Exec. Director of Fin. & Controller", "yearBorn": 1986, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Firuz  Shakoori", "title": "Head of CMC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Claire Susan Padgett M.S., M.T., Ph.D.", "title": "Sr. VP of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Rekha  Garg M.D., M.S.", "title": "Sr. VP of Clinical Devel. & Regulatory", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}